Stay updated with breaking news from Barrier Formation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A recent Cornell University study sheds fresh light on how the chemotherapy medication etoposide slows and destroys critical enzymes that drive cancer cell development.
New Cornell research is providing a fresh view into the ways a common chemotherapy agent, etoposide, stalls and poisons the essential enzymes that allow cancer cells to flourish.
New Cornell research is providing a fresh view into the ways a common chemotherapy agent, etoposide, stalls and poisons the essential enzymes that allow cancer cells to flourish.
During a Society for Investigative Dermatology e-poster session, Amorepacific shared research uncovering the role of EGR3 in skin barrier functioning and its connection with compromised skin.